Skip to main content
Top
Published in: Journal of Neurology 2/2016

01-02-2016 | Original Communication

NEFL N98S mutation: another cause of dominant intermediate Charcot–Marie–Tooth disease with heterogeneous early-onset phenotype

Authors: José Berciano, Kristien Peeters, Antonio García, Tomás López-Alburquerque, Elena Gallardo, Arantxa Hernández-Fabián, Ana L. Pelayo-Negro, Els De Vriendt, Jon Infante, Albena Jordanova

Published in: Journal of Neurology | Issue 2/2016

Login to get access

Abstract

The purpose of this study was to describe a pedigree with NEFL N98S mutation associated with a dominant intermediate Charcot–Marie–Tooth disease (DI-CMT) and heterogeneous early-onset phenotype. The pedigree comprised two patients, the proband and her son, aged 38 and 5 years. The proband, evaluated at age 31, showed delayed motor milestones that, as of the second decade, evolved into severe phenotype consisting of sensorimotor neuropathy, pes cavus, clawing hands, gait and kinetic cerebellar ataxia, nystagmus and dysarthria, she being wheelchair bound. By then, a working diagnosis of sporadic early onset cerebellar ataxia with peripheral neuropathy was established. Screening of mutations associated with SCA and autosomal recessive cerebellar ataxias was negative. Her son showed a mild phenotype characterized by delayed motor milestones, and lower-limb hypotonia and areflexia. Electrophysiology in both patients showed nerve conduction slowing in the intermediate range, both in proximal and distal nerve segments, but where compound muscle action potentials exhibited severe attenuation there was conduction slowing down to the demyelinating range. In the proband, cranial magnetic resonance imaging (MRI) showed cerebellar atrophy, electromyography disclosed active denervation in tibialis anterior, and MRI of lower-limb musculature demonstrated widespread and distally accentuated muscle fatty atrophy; furthermore, on water sensitive MRI sequences there was edema of calf muscles. We conclude that the NEFL N98S mutation is associated with a DI-CMT phenotype characterized by early-onset sensorimotor neuropathy delaying motor milestones, which may evolve into a severe and complex clinical picture including cerebellar ataxia.
Literature
1.
go back to reference Combarros O, Calleja J, Polo JM, Berciano J (1987) Prevalence of hereditary motor and sensory neuropathy in Cantabria. Acta Neurol Scand 75:9–12CrossRefPubMed Combarros O, Calleja J, Polo JM, Berciano J (1987) Prevalence of hereditary motor and sensory neuropathy in Cantabria. Acta Neurol Scand 75:9–12CrossRefPubMed
2.
go back to reference Harding AE, Thomas PK (1980) The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103:259–280CrossRefPubMed Harding AE, Thomas PK (1980) The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103:259–280CrossRefPubMed
3.
go back to reference Davis CJ, Bradley WG, Madrid R (1978) The peroneal muscular atrophy syndrome: clinical, genetic, electrophysiological and nerve biopsy studies. I. Clinical, genetic and electrophysiological findings and classification. J Genet Hum 26:311–349PubMed Davis CJ, Bradley WG, Madrid R (1978) The peroneal muscular atrophy syndrome: clinical, genetic, electrophysiological and nerve biopsy studies. I. Clinical, genetic and electrophysiological findings and classification. J Genet Hum 26:311–349PubMed
4.
go back to reference Madrid R, Bradley WG, Davis CJ (1977) The peroneal muscular atrophy syndrome. Clinical, genetic, electrophysiological and nerve biopsy studies. Part 2. Observations on pathological changes in sural nerve biopsies. J Neurol Sci 32:91–122CrossRefPubMed Madrid R, Bradley WG, Davis CJ (1977) The peroneal muscular atrophy syndrome. Clinical, genetic, electrophysiological and nerve biopsy studies. Part 2. Observations on pathological changes in sural nerve biopsies. J Neurol Sci 32:91–122CrossRefPubMed
5.
go back to reference Bouché P, Gherardi R, Cathala HP, Lhermitte F, Castaigne P (1983) Peroneal muscular atrophy. Part 1. Clinical and electrophysiological study. J Neurol Sci 61:389–399CrossRefPubMed Bouché P, Gherardi R, Cathala HP, Lhermitte F, Castaigne P (1983) Peroneal muscular atrophy. Part 1. Clinical and electrophysiological study. J Neurol Sci 61:389–399CrossRefPubMed
6.
go back to reference Nicholson G, Myers S (2006) Intermediate forms of Charcot–Marie–Tooth neuropathy: a review. Neuromolecular Med 8:123–130PubMed Nicholson G, Myers S (2006) Intermediate forms of Charcot–Marie–Tooth neuropathy: a review. Neuromolecular Med 8:123–130PubMed
7.
go back to reference Banchs I, Casasnovas C, Montero J, Volpini V, Martínez-Matos JA (2010) Charcot–Marie–Tooth disease with intermediate conduction velocities caused by a novel mutation in the MPZ gene. Muscle Nerve 42:184–188CrossRefPubMed Banchs I, Casasnovas C, Montero J, Volpini V, Martínez-Matos JA (2010) Charcot–Marie–Tooth disease with intermediate conduction velocities caused by a novel mutation in the MPZ gene. Muscle Nerve 42:184–188CrossRefPubMed
8.
go back to reference Berciano J, García A, Peeters K, Gallardo E, De Vriendt E, Pelayo-Negro AL, Infante J, Jordanova A (2015) NEFL E396K mutation is associated with a novel dominant intermediate Charcot–Marie–Tooth disease phenotype. J Neurol 262:1289–1300CrossRefPubMed Berciano J, García A, Peeters K, Gallardo E, De Vriendt E, Pelayo-Negro AL, Infante J, Jordanova A (2015) NEFL E396K mutation is associated with a novel dominant intermediate Charcot–Marie–Tooth disease phenotype. J Neurol 262:1289–1300CrossRefPubMed
9.
go back to reference Rossor AM, Polke JM, Houlden H, Reilly MM (2013) Clinical implications of genetic advances in Charcot–Marie–Tooth disease. Nat Rev Neurol 9:562–571CrossRefPubMed Rossor AM, Polke JM, Houlden H, Reilly MM (2013) Clinical implications of genetic advances in Charcot–Marie–Tooth disease. Nat Rev Neurol 9:562–571CrossRefPubMed
10.
go back to reference Nicholson G, Nash J (1993) Intermediate nerve conduction velocities define X-linked Charcot–Marie–Tooth neuropathy families. Neurology 43:2558–2564CrossRefPubMed Nicholson G, Nash J (1993) Intermediate nerve conduction velocities define X-linked Charcot–Marie–Tooth neuropathy families. Neurology 43:2558–2564CrossRefPubMed
12.
go back to reference Mersiyanova IV, Perepelov AV, Polyakov AV, Sitnikov VF, Dadali EL, Oparin RB, Petrin AN, Evgrafov OV (2009) A new variant of Charcot–Marie–Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 67:37–46CrossRef Mersiyanova IV, Perepelov AV, Polyakov AV, Sitnikov VF, Dadali EL, Oparin RB, Petrin AN, Evgrafov OV (2009) A new variant of Charcot–Marie–Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 67:37–46CrossRef
13.
go back to reference De Jonghe P, Mersivanova I, Nelis E, Del Favero J, Martin JJ, Van Broeckhoven C, Evgrafov O, Timmerman V (2001) Further evidence that neurofilament light chain gene mutations can cause Charcot–Marie–Tooth disease type 2E. Ann Neurol 49:245–249CrossRefPubMed De Jonghe P, Mersivanova I, Nelis E, Del Favero J, Martin JJ, Van Broeckhoven C, Evgrafov O, Timmerman V (2001) Further evidence that neurofilament light chain gene mutations can cause Charcot–Marie–Tooth disease type 2E. Ann Neurol 49:245–249CrossRefPubMed
14.
go back to reference Georgiou DM, Zidar J, Korosec M, Middleton LT, Kyriakides T, Christodoulou K (2002) A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family. Neurogenetics 4:93–96CrossRefPubMed Georgiou DM, Zidar J, Korosec M, Middleton LT, Kyriakides T, Christodoulou K (2002) A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family. Neurogenetics 4:93–96CrossRefPubMed
15.
go back to reference Jordanova A, De Jonghe P, Boerkoel CF, Takashima H, De Vriendt E, Ceuterick C, Martin JJ, Butler IJ, Mancias P, Papasozomenos SCh, Terespolsky D, Potocki L, Brown CW, Shy M, Rita DA, Tournev I, Kremensky I, Lupski JR, Timmerman V (2003) Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot–Marie–Tooth disease. Brain 126:590–597CrossRefPubMed Jordanova A, De Jonghe P, Boerkoel CF, Takashima H, De Vriendt E, Ceuterick C, Martin JJ, Butler IJ, Mancias P, Papasozomenos SCh, Terespolsky D, Potocki L, Brown CW, Shy M, Rita DA, Tournev I, Kremensky I, Lupski JR, Timmerman V (2003) Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot–Marie–Tooth disease. Brain 126:590–597CrossRefPubMed
16.
go back to reference Züchner S, Vorgerd M, Sindern E, Schröder JM (2004) The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot–Marie–Tooth neuropathy. Neuromuscul Disord 14:147–157CrossRefPubMed Züchner S, Vorgerd M, Sindern E, Schröder JM (2004) The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot–Marie–Tooth neuropathy. Neuromuscul Disord 14:147–157CrossRefPubMed
17.
go back to reference Fabrizi GM, Cavallaro T, Angiari C, Cabrini I, Taioli F, Malerba G, Bertolasi L, Rizzuto N (2007) Charcot–Marie–Tooth disease type 2E, a disorder of the cytoskeleton. Brain 130:394–403CrossRefPubMed Fabrizi GM, Cavallaro T, Angiari C, Cabrini I, Taioli F, Malerba G, Bertolasi L, Rizzuto N (2007) Charcot–Marie–Tooth disease type 2E, a disorder of the cytoskeleton. Brain 130:394–403CrossRefPubMed
18.
19.
go back to reference Abe A, Numakura C, Saito K, Koide H, Oka N, Honma A, Kishikawa Y, Hayasaka K (2009) Neurofilament light chain polypeptide gene mutations in Charcot–Marie–Tooth disease: nonsense mutation probably causes a recessive phenotype. J Hum Genet 54:94–97CrossRefPubMed Abe A, Numakura C, Saito K, Koide H, Oka N, Honma A, Kishikawa Y, Hayasaka K (2009) Neurofilament light chain polypeptide gene mutations in Charcot–Marie–Tooth disease: nonsense mutation probably causes a recessive phenotype. J Hum Genet 54:94–97CrossRefPubMed
20.
go back to reference Miltenberger-Miltenyi G, Janecke AR, Wanschitz JV, Timmerman V, Windpassinger C, Auer-Grumbach M, Löscher WN (2007) Clinical and electrophysiological features in Charcot–Marie–Tooth disease with mutations in the NEFL gene. Arch Neurol 64:966–970CrossRefPubMed Miltenberger-Miltenyi G, Janecke AR, Wanschitz JV, Timmerman V, Windpassinger C, Auer-Grumbach M, Löscher WN (2007) Clinical and electrophysiological features in Charcot–Marie–Tooth disease with mutations in the NEFL gene. Arch Neurol 64:966–970CrossRefPubMed
21.
go back to reference Pisciotta C, Bai Y, Brennan KM, Wu X, Grider T, Feely S, Wang S, Moore S, Siskind C, Gonzalez M, Zuchner S, Shy ME (2015) Reduced neurofilament expression in cutaneous nerve fibers of patients with CMT2E. Neurology 85:228–234CrossRefPubMedPubMedCentral Pisciotta C, Bai Y, Brennan KM, Wu X, Grider T, Feely S, Wang S, Moore S, Siskind C, Gonzalez M, Zuchner S, Shy ME (2015) Reduced neurofilament expression in cutaneous nerve fibers of patients with CMT2E. Neurology 85:228–234CrossRefPubMedPubMedCentral
22.
go back to reference Lin KP, Soong BW, Yang CC, Huang LW, Chang MH, Lee IH, Antonellis A, Lee YC (2011) The mutational spectrum in a cohort of Charcot–Marie–Tooth disease type 2 among the Han Chinese in Taiwan. PLoS One 6:e29393CrossRefPubMedPubMedCentral Lin KP, Soong BW, Yang CC, Huang LW, Chang MH, Lee IH, Antonellis A, Lee YC (2011) The mutational spectrum in a cohort of Charcot–Marie–Tooth disease type 2 among the Han Chinese in Taiwan. PLoS One 6:e29393CrossRefPubMedPubMedCentral
23.
go back to reference Saporta AS, Sottile SL, Miller LJ, Feely SM, Siskind CE, Shy ME (2011) Charcot–Marie–Tooth disease subtypes and genetic testing strategies. Ann Neurol 69:22–33CrossRefPubMedPubMedCentral Saporta AS, Sottile SL, Miller LJ, Feely SM, Siskind CE, Shy ME (2011) Charcot–Marie–Tooth disease subtypes and genetic testing strategies. Ann Neurol 69:22–33CrossRefPubMedPubMedCentral
24.
go back to reference Murphy SM, Laura M, Fawcett K, Pandraud A, Liu YT, Davidson GL, Rossor AM, Polke JM, Castleman V, Manji H, Lunn MP, Bull K, Ramdharry G, Davis M, Blake JC, Houlden H, Reilly MM (2012) Charcot–Marie–Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J Neurol Neurosurg Psychiatry 83:706–710CrossRefPubMedPubMedCentral Murphy SM, Laura M, Fawcett K, Pandraud A, Liu YT, Davidson GL, Rossor AM, Polke JM, Castleman V, Manji H, Lunn MP, Bull K, Ramdharry G, Davis M, Blake JC, Houlden H, Reilly MM (2012) Charcot–Marie–Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J Neurol Neurosurg Psychiatry 83:706–710CrossRefPubMedPubMedCentral
25.
go back to reference Sivera R, Sevilla T, Vílchez JJ, Martínez-Rubio D, Chumillas MJ, Vázquez JF, Muelas N, Bataller L, Millán JM, Palau F, Espinós C (2013) Charcot–Marie–Tooth disease: genetic and clinical spectrum in a Spanish clinical series. Neurology 81:1617–1625CrossRefPubMedPubMedCentral Sivera R, Sevilla T, Vílchez JJ, Martínez-Rubio D, Chumillas MJ, Vázquez JF, Muelas N, Bataller L, Millán JM, Palau F, Espinós C (2013) Charcot–Marie–Tooth disease: genetic and clinical spectrum in a Spanish clinical series. Neurology 81:1617–1625CrossRefPubMedPubMedCentral
26.
go back to reference Yoshihara T, Yamamoto M, Hattori N, Misu K, Mori K, Koike H, Sobue G (2002) Identification of novel sequence variants in the neurofilament-light gene in a Japanese population: analysis of Charcot–Marie–Tooth disease patients and normal individuals. J Peripher Nerv Syst 7:221–224CrossRefPubMed Yoshihara T, Yamamoto M, Hattori N, Misu K, Mori K, Koike H, Sobue G (2002) Identification of novel sequence variants in the neurofilament-light gene in a Japanese population: analysis of Charcot–Marie–Tooth disease patients and normal individuals. J Peripher Nerv Syst 7:221–224CrossRefPubMed
27.
go back to reference Baets J, Deconinck T, De Vriendt E, Zimoń M, Yperzeele L, Van Hoorenbeeck K, Peeters K, Spiegel R, Parman Y, Ceulemans B, Van Bogaert P, Pou-Serradell A, Bernert G, Dinopoulos A, Auer-Grumbach M, Sallinen SL, Fabrizi GM, Pauly F, Van den Bergh P, Bilir B, Battaloglu E, Madrid RE, Kabzińska D, Kochanski A, Topaloglu H, Miller G, Jordanova A, Timmerman V, De Jonghe P (2011) Genetic spectrum of hereditary neuropathies with onset in the first year of life. Brain 134:2664–2676CrossRefPubMedPubMedCentral Baets J, Deconinck T, De Vriendt E, Zimoń M, Yperzeele L, Van Hoorenbeeck K, Peeters K, Spiegel R, Parman Y, Ceulemans B, Van Bogaert P, Pou-Serradell A, Bernert G, Dinopoulos A, Auer-Grumbach M, Sallinen SL, Fabrizi GM, Pauly F, Van den Bergh P, Bilir B, Battaloglu E, Madrid RE, Kabzińska D, Kochanski A, Topaloglu H, Miller G, Jordanova A, Timmerman V, De Jonghe P (2011) Genetic spectrum of hereditary neuropathies with onset in the first year of life. Brain 134:2664–2676CrossRefPubMedPubMedCentral
28.
go back to reference García A, Combarros O, Calleja J, Berciano J (1998) Charcot–Marie–Tooth disease type 1A with 17p duplication in infancy and early childhood: a longitudinal clinical and electrophysiologic study. Neurology 5:1061–1067CrossRef García A, Combarros O, Calleja J, Berciano J (1998) Charcot–Marie–Tooth disease type 1A with 17p duplication in infancy and early childhood: a longitudinal clinical and electrophysiologic study. Neurology 5:1061–1067CrossRef
29.
go back to reference Berciano J, Gallardo E, García A, Infante J, Mateo I, Combarros O (2006) Charcot–Marie–Tooth disease type 1A duplication with severe paresis of the proximal lower limb muscles: a long-term follow-up study. J Neurol Neurosurg Psychiatry 77:1169–1176CrossRefPubMedPubMedCentral Berciano J, Gallardo E, García A, Infante J, Mateo I, Combarros O (2006) Charcot–Marie–Tooth disease type 1A duplication with severe paresis of the proximal lower limb muscles: a long-term follow-up study. J Neurol Neurosurg Psychiatry 77:1169–1176CrossRefPubMedPubMedCentral
30.
go back to reference Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, Li J, Lewis RA, Reilly M (2005) Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64:1209–1214CrossRefPubMed Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, Li J, Lewis RA, Reilly M (2005) Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64:1209–1214CrossRefPubMed
31.
go back to reference Amato AA, Gronseth GS, Callerame KJ, Kagan-Hallet KS, Bryan WW, Barohn RJ (1996) Tomaculous neuropathy: a clinical and electrophysiological study in patients with and without 1.5-Mb deletions in chromosome 17p11.2. Muscle Nerve 19:16–22CrossRefPubMed Amato AA, Gronseth GS, Callerame KJ, Kagan-Hallet KS, Bryan WW, Barohn RJ (1996) Tomaculous neuropathy: a clinical and electrophysiological study in patients with and without 1.5-Mb deletions in chromosome 17p11.2. Muscle Nerve 19:16–22CrossRefPubMed
32.
go back to reference Chiappa KH (1997) Evoked potentials in clinical medicine, 3rd edn. Lippincott-Raven Press Publishers, Philadelphia-New York Chiappa KH (1997) Evoked potentials in clinical medicine, 3rd edn. Lippincott-Raven Press Publishers, Philadelphia-New York
33.
go back to reference Cruz Martínez A, Pérez Conde MC, Del Campo F, Barrio M, Gutiérrez AM, López E (1978) Sensory and mixed conduction velocity in infancy and childhood: I. Normal parameters in median, ulnar and sural nerves. Electromiogr Clin Neurophysiol 18:487–504 Cruz Martínez A, Pérez Conde MC, Del Campo F, Barrio M, Gutiérrez AM, López E (1978) Sensory and mixed conduction velocity in infancy and childhood: I. Normal parameters in median, ulnar and sural nerves. Electromiogr Clin Neurophysiol 18:487–504
34.
go back to reference García A, Calleja J, Antolín FM, Berciano J (2000) Peripheral motor and sensory nerve conduction studies in normal infants and children. Clin Neurophysiol 111:513–520CrossRefPubMed García A, Calleja J, Antolín FM, Berciano J (2000) Peripheral motor and sensory nerve conduction studies in normal infants and children. Clin Neurophysiol 111:513–520CrossRefPubMed
35.
go back to reference Gallardo E, García A, Combarros O, Berciano J (2006) Charcot–Marie–Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles. Brain 129:426–437CrossRefPubMed Gallardo E, García A, Combarros O, Berciano J (2006) Charcot–Marie–Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles. Brain 129:426–437CrossRefPubMed
36.
go back to reference Reumers J, De Rijk P, Zhao H, Liekens A, Smeets D, Cleary J, Van Loo P, Van Den Bossche M, Catthoor K, Sabbe B, Despierre E, Vergote I, Hilbush B, Lambrechts D, Del-Favero J (2011) Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing. Nat Biotechnol 18(30):61–68CrossRef Reumers J, De Rijk P, Zhao H, Liekens A, Smeets D, Cleary J, Van Loo P, Van Den Bossche M, Catthoor K, Sabbe B, Despierre E, Vergote I, Hilbush B, Lambrechts D, Del-Favero J (2011) Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing. Nat Biotechnol 18(30):61–68CrossRef
37.
go back to reference Boyer O, Nevo F, Plaisier E, Funalot B, Gribouval O, Benoit G, Huynh Cong E, Arrondel C, Tête MJ, Montjean R, Richard L, Karras A, Pouteil-Noble C, Balafrej L, Bonnardeaux A, Canaud G, Charasse C, Dantal J, Deschenes G, Deteix P, Dubourg O, Petiot P, Pouthier D, Leguern E, Guiochon-Mantel A, Broutin I, Gubler MC, Saunier S, Ronco P, Vallat JM, Alonso MA, Antignac C, Mollet G (2011) INF2 mutations in Charcot–Marie–Tooth disease with glomerulopathy. N Engl J Med 365:2377–2388CrossRefPubMed Boyer O, Nevo F, Plaisier E, Funalot B, Gribouval O, Benoit G, Huynh Cong E, Arrondel C, Tête MJ, Montjean R, Richard L, Karras A, Pouteil-Noble C, Balafrej L, Bonnardeaux A, Canaud G, Charasse C, Dantal J, Deschenes G, Deteix P, Dubourg O, Petiot P, Pouthier D, Leguern E, Guiochon-Mantel A, Broutin I, Gubler MC, Saunier S, Ronco P, Vallat JM, Alonso MA, Antignac C, Mollet G (2011) INF2 mutations in Charcot–Marie–Tooth disease with glomerulopathy. N Engl J Med 365:2377–2388CrossRefPubMed
38.
go back to reference Gentile L, Taioli F, Fabrizi GM, Russo M, Stancanelli C, Mazzeo A (2013) Considerable post-partum worsening in a patient with CMT2E. Neurol Sci 34:1813–1814CrossRefPubMed Gentile L, Taioli F, Fabrizi GM, Russo M, Stancanelli C, Mazzeo A (2013) Considerable post-partum worsening in a patient with CMT2E. Neurol Sci 34:1813–1814CrossRefPubMed
39.
go back to reference Berciano J, García A, Infante J (2013) Peripheral nerve involvement in hereditary cerebellar and multisystem degenerative disorders. Handb Clin Neurol 115:907–932CrossRefPubMed Berciano J, García A, Infante J (2013) Peripheral nerve involvement in hereditary cerebellar and multisystem degenerative disorders. Handb Clin Neurol 115:907–932CrossRefPubMed
40.
go back to reference García A, Criscuolo C, de Michele G, Berciano J (2008) Neurophysiological study in a Spanish family with recessive spastic ataxia of Charlevoix-Saguenay. Muscle Nerve 37:107–110CrossRefPubMed García A, Criscuolo C, de Michele G, Berciano J (2008) Neurophysiological study in a Spanish family with recessive spastic ataxia of Charlevoix-Saguenay. Muscle Nerve 37:107–110CrossRefPubMed
41.
go back to reference Fabrizi GM, Cavallaro T, Angiari C, Bertolasi L, Cabrini I, Ferrarini M, Rizzuto N (2004) Giant axon and neurofilament accumulation in Charcot–Marie–Tooth disease type 2E. Neurology 62:1429–1431CrossRefPubMed Fabrizi GM, Cavallaro T, Angiari C, Bertolasi L, Cabrini I, Ferrarini M, Rizzuto N (2004) Giant axon and neurofilament accumulation in Charcot–Marie–Tooth disease type 2E. Neurology 62:1429–1431CrossRefPubMed
42.
go back to reference Elbracht M, Senderek J, Schara U, Nolte K, Klopstock T, Roos A, Reimann J, Zerres K, Weis J, Rudnik-Schöneborn S (2014) Clinical and morphological variability of the E396K mutation in the neurofilament light chain gene in patients with Charcot–Marie–Tooth disease type 2E. Clin Neuropathol 33:335–343CrossRefPubMed Elbracht M, Senderek J, Schara U, Nolte K, Klopstock T, Roos A, Reimann J, Zerres K, Weis J, Rudnik-Schöneborn S (2014) Clinical and morphological variability of the E396K mutation in the neurofilament light chain gene in patients with Charcot–Marie–Tooth disease type 2E. Clin Neuropathol 33:335–343CrossRefPubMed
43.
go back to reference Shin JS, Chung KW, Cho SY, Yun J, Hwang SJ, Kang SH, Cho EM, Kim SM, Choi BO (2008) NEFL Pro22Arg mutation in Charcot–Marie–Tooth disease type 1. J Hum Genet 53:936–940CrossRefPubMed Shin JS, Chung KW, Cho SY, Yun J, Hwang SJ, Kang SH, Cho EM, Kim SM, Choi BO (2008) NEFL Pro22Arg mutation in Charcot–Marie–Tooth disease type 1. J Hum Genet 53:936–940CrossRefPubMed
44.
go back to reference Waxman SG (1980) Determinants of conduction velocity in myelinated nerve fibers. Muscle Nerve 3:141–150CrossRefPubMed Waxman SG (1980) Determinants of conduction velocity in myelinated nerve fibers. Muscle Nerve 3:141–150CrossRefPubMed
45.
go back to reference Perrot R, Berges R, Bocquet A, Eyer J (2008) Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration. Mol Neurobiol 38:27–65CrossRefPubMed Perrot R, Berges R, Bocquet A, Eyer J (2008) Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration. Mol Neurobiol 38:27–65CrossRefPubMed
46.
go back to reference Adebola AA, Di Castri T, He C, Salvatierra LA, Zhao J, Brown K, Lin C, Worman HJ, Liem RK (2015) Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnormalities and a Charcot–Marie–Tooth Type 2E phenotype. Hum Mol Genet 24:2163–2174CrossRefPubMed Adebola AA, Di Castri T, He C, Salvatierra LA, Zhao J, Brown K, Lin C, Worman HJ, Liem RK (2015) Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnormalities and a Charcot–Marie–Tooth Type 2E phenotype. Hum Mol Genet 24:2163–2174CrossRefPubMed
47.
go back to reference Kamath S, Venkatanarasimha N, Walsh MA, Hughes PM (2008) MRI appearance of muscle denervation. Skeletal Radiol 37:397–404CrossRefPubMed Kamath S, Venkatanarasimha N, Walsh MA, Hughes PM (2008) MRI appearance of muscle denervation. Skeletal Radiol 37:397–404CrossRefPubMed
48.
go back to reference Chung KW, Suh BC, Shy ME, Cho SY, Yoo JH, Park SW, Moon H, Park KD, Choi KG, Kim S, Kim SB, Shim DS, Kim SM, Sunwoo IN, Choi BO (2008) Different clinical and magnetic resonance imaging features between Charcot–Marie–Tooth disease type 1A and 2A. Neuromuscul Disord 18:610–618CrossRefPubMed Chung KW, Suh BC, Shy ME, Cho SY, Yoo JH, Park SW, Moon H, Park KD, Choi KG, Kim S, Kim SB, Shim DS, Kim SM, Sunwoo IN, Choi BO (2008) Different clinical and magnetic resonance imaging features between Charcot–Marie–Tooth disease type 1A and 2A. Neuromuscul Disord 18:610–618CrossRefPubMed
Metadata
Title
NEFL N98S mutation: another cause of dominant intermediate Charcot–Marie–Tooth disease with heterogeneous early-onset phenotype
Authors
José Berciano
Kristien Peeters
Antonio García
Tomás López-Alburquerque
Elena Gallardo
Arantxa Hernández-Fabián
Ana L. Pelayo-Negro
Els De Vriendt
Jon Infante
Albena Jordanova
Publication date
01-02-2016
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 2/2016
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7985-z

Other articles of this Issue 2/2016

Journal of Neurology 2/2016 Go to the issue